The first RP-UHPLC method for simultaneous quantification of abiraterone acetate, its four degradants, and six specified process impurities and correct identification of all analytes based on molecular weight
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The first RP-UHPLC method for simultaneous quantification of abiraterone acetate, its four degradants, and six specified process impurities and correct identification of all analytes based on molecular weight
Authors
Keywords
-
Journal
Journal of Pharmaceutical and Biomedical Analysis
Volume 234, Issue -, Pages 115568
Publisher
Elsevier BV
Online
2023-07-11
DOI
10.1016/j.jpba.2023.115568
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Simultaneous determination of abiraterone and its five metabolites in human plasma by LC-MS/MS: Application to pharmacokinetic study in healthy Chinese subjects
- (2022) Yixin Hu et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Determination of Abiraterone and Its Metabolites in Human Serum by LC-ESI-TOF/MS Using Solid-phase Extraction
- (2021) Hiromi KANJI et al. ANALYTICAL SCIENCES
- AQbD Driven Development of an RP-HPLC Method for the Quantitation of Abiraterone Acetate for its Pharmaceutical Formulations in the Presence of Degradants
- (2021) Bikash Ranjan JENA et al. Turkish Journal of Pharmaceutical Sciences
- A Rapid, Direct and Validated HPLC- Fluorescence Method for the Quantification of Abiraterone and Abiraterone Acetate in Urine and Serum Samples from Patients with Castration- Resistant Prostate Cancer
- (2018) Juana Rodriguez et al. Current Pharmaceutical Analysis
- Identification, Characterization and High-Performance Liquid Chromatography Quantification for Process-Related Impurities in Abiraterone Acetate Bulk Drug
- (2018) Changjie Hu et al. JOURNAL OF CHROMATOGRAPHIC SCIENCE
- Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry
- (2018) Atul Bhatnagar et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Development and validation of a novel LC–MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column
- (2017) Mohammad Alyamani et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Development and Validation of an LC-MS/MS Method for the Simultaneous Quantification of Abiraterone, Enzalutamide, and Their Major Metabolites in Human Plasma
- (2017) Merel van Nuland et al. THERAPEUTIC DRUG MONITORING
- A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancer
- (2015) Tiphaine Belleville et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- β-cyclodextrin Sensitized Spectrofluorimetry for the Determination of Abiraterone Acetate and Abiraterone
- (2013) Aiqin Gong et al. JOURNAL OF FLUORESCENCE
- CYP17 inhibitors—abiraterone, C17,20-lyase inhibitors and multi-targeting agents
- (2013) Lina Yin et al. Nature Reviews Urology
- Validated RP-HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats
- (2012) S. Vijay Kumar et al. BIOMEDICAL CHROMATOGRAPHY
- Analysis of abiraterone stress degradation behavior using liquid chromatography coupled to ultraviolet detection and electrospray ionization mass spectrometry
- (2012) Alaa Khedr et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started